| Literature DB >> 19025391 |
Daniel M Kaplon1, Harry Iannotti.
Abstract
The use of lasers for management of benign prostatic hyperplasia has evolved greatly over the last several years. The 120-W potassium-titanyl-phosphate laser, introduced in 2006 as the GreenLight HPS, boasts a 50% improvement in power over the 80-W laser with theoretical benefit of greater vaporization ability and decreased surgery times. Because of higher energy applied to the tissue, there is also a theoretical risk of increased complications related to capsular perforation or injury to adjacent organs. We report a case involving perforation of the anterior prostatic capsule leading to extravasation and osteomyelitis of the pubic bone.Entities:
Mesh:
Year: 2008 PMID: 19025391 DOI: 10.1089/end.2008.0206
Source DB: PubMed Journal: J Endourol ISSN: 0892-7790 Impact factor: 2.942